Search Results
10
Everything
Search Filters
Tag
Clinical Trials
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
March 12, 2025 08:30 ET
|
Dogwood Therapeutics, Inc.
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class,...
Clinical Trials Market Forecast Report 2025: A $99.25 Billion Industry by 2033, Driven by Acceptance of Decentralized Experiments, Shift Towards Personalized Medicine, Demand for Effective Treatments
March 10, 2025 10:18 ET
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033" report has been added to ...
New Seminar: FDA Compliance and Clinical Trial Computer System Validation Core Requirements, Expectations and Challenges (ONLINE EVENT: April 9-10, 2025)
March 10, 2025 08:47 ET
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "FDA Compliance and Clinical Trial Computer System Validation Core Requirements, Expectations and Challenges" training has been added to ...
Global eClinical Solutions Market Size to Hit USD 31.90 Billion by 2032 – SNS Insider
March 07, 2025 09:10 ET
|
SNS Insider pvt ltd
Pune, March 07, 2025 (GLOBE NEWSWIRE) -- eClinical Solutions Market Size & Growth Analysis: According to SNS Insider, the global eClinical Solutions Market size was valued at USD 9.82 Billion...
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma
March 07, 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda
Rare Disease Clinical Trials Market Landscape Report 2024: Phase, Single Versus Multinational, Geography, Sponsor Type, Therapy Area, Indication, Top Sponsors, Drug Type, and DCT Use
March 07, 2025 06:30 ET
|
Research and Markets
Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials: Rare Disease" report has been added to ResearchAndMarkets.com's offering.Understand the clinical trial landscape of rare disease...
Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration
March 06, 2025 08:00 ET
|
Allarity Therapeutics, Inc.
Trial to explore novel combination therapy for patients with recurrent Small Cell Lung Cancer who have failed frontline treatment Fully funded by the U.S. Veterans’ Administration Special Emphasis...
Plus Therapeutics Announces New Employment Inducement Grants
March 05, 2025 16:01 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
Osteoporosis Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
March 05, 2025 10:50 ET
|
Research and Markets
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis_Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
Myelodysplastic Syndrome Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
March 03, 2025 09:16 ET
|
Research and Markets
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering.The clinical trial report...